Oracity Life Sciences LLP
About Oracity Life Sciences LLP
Data last updated:
Oracity Life Sciences LLP is a limited liability partnership (LLP) based in Hingna, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 August 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAN-0860. Its GSTIN is 27AAGFO0667F1Z9 (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Paramveer Abhay Sancheti and Ajit Parasmal Soni.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Hingna, Maharashtra.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹3.17 Cr, a growth of 108% compared to the previous year. For the same year it recorded a net loss of ₹4.03 Cr (net margin -126.9%) and EBITDA of -₹1.08 Cr (EBITDA margin -34.1%). Revenue has grown at a compounded annual rate (CAGR) of 384% over five years.
The LLP has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹7.75 Cr and satisfied charges of ₹3.5 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 4 Phase II Industrial Area, Opposite Horiba MIDC, Hingna, Maharashtra, India – 441122
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Oracity Life Sciences LLP FY 2025 filings available
Oracity Life Sciences LLP reported revenue of ₹3.17 Cr (up 108% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Oracity Life Sciences LLP
Revenue has grown at a compounded annual rate (CAGR) of 384% over five years, including 108% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Oracity Life Sciences LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹3.17 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | -₹4.03 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Oracity Life Sciences LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | -126.9% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Oracity Life Sciences are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Oracity Life Sciences LLP
Oracity Life Sciences has 2 current designated partners and 3 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Paramveer Abhay Sancheti | Designated Partner | 11 Mar 2024 | 2 Years 6 Months | Current |
| Ajit Parasmal Soni Also directs: Clean Code Solutions LLP | Designated Partner | 02 Aug 2018 | 8 Years 2 Months | Current |
Ownership and Shareholding of Oracity Life Sciences LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Oracity Life Sciences LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2020 | Bank of Maharashtra | ₹7.75 Cr | Open |
| 19 Sep 2019 | Wardhaman Urban Co-Operative Bank Limited | ₹3.5 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Oracity Life Sciences LLP
Oracity Life Sciences LLP has a workforce of 16 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Oracity Life Sciences LLP
Oracity Life Sciences LLP has 5 designated partner changes on record since 2018: 2 appointments and 3 cessations. The latest: Amit Kedarnath Somani ceased to be Partner on 12 Mar 2024.
Credit Ratings, Litigation & Regulatory Alerts for Oracity Life Sciences LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Oracity Life Sciences LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Oracity Life Sciences LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Oracity Life Sciences LLP
Oracity Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGFO0667F1Z9 | Maharashtra | Active | 01 Sep 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Oracity Life Sciences LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oracity Life Sciences LLP
Oracity Life Sciences is an active limited liability partnership based in Hingna, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 02 August 2018 (8+ years old) and is registered under LLPIN AAN-0860.
Oracity Life Sciences reported revenue of ₹3.17 Cr for FY 2024 (up 108% YoY).
Oracity Life Sciences has 2 current designated partners:
- Paramveer Abhay Sancheti - Designated Partner
- Ajit Parasmal Soni - Designated Partner
Oracity Life Sciences reported a net loss of ₹4.03 Cr (net margin -126.9%) and EBITDA of -₹1.08 Cr (EBITDA margin -34.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Oracity Life Sciences is 384% over five years. In the latest year (FY 2024) revenue rose 108%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Oracity Life Sciences is 27AAGFO0667F1Z9, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Oracity Life Sciences is AAN-0860. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Oracity Life Sciences was incorporated on 02 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Amit Kedarnath Somani ceased to be Partner on 12 Mar 2024. Mangesh Eknath Bhad ceased to be Designated Partner on 12 Mar 2024. Paramveer Abhay Sancheti was appointed as Designated Partner on 11 Mar 2024. Oracity Life Sciences has 5 designated partner changes on record in total.
The registered office of Oracity Life Sciences is at B – 4 Phase II Industrial Area, Opposite Horiba MIDC, Hingna, Maharashtra, India – 441122.